Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives

Published:2020-01 Issue:1 Volume:31 Page:30-40
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Martinelli E.,Ciardiello D.,Martini G.,Troiani T.,Cardone C.,Vitiello P.P.,Normanno N.,Rachiglio A.M.,Maiello E.,Latiano T.,De Vita F.,Ciardiello F.

Funder

Associazione Italiana per la Ricerca sul Cancro

Regione Campania

Sanofi

Amgen

Merck KgA

Roche

Servier

Bayer

Array

MSD

BMS

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference90 articles.

1. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer;J Clin Oncol,1998

2. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer;Van Cutsem;Ann Oncol,2016

3. EGFR antagonists in cancer treatment;Ciardiello;N Engl J Med,2008

4. Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer;Van Cutsem;J Clin Oncol,2015

5. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: The OPUS study;Bokemeyer;Ann Oncol,2011

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging magic bullet: subcellular organelle-targeted cancer therapy;Medical Review;2024-09-12

2. Palmitoyltransferase ZDHHC6 promotes colon tumorigenesis by targeting PPARγ-driven lipid biosynthesis via regulating lipidome metabolic reprogramming;Journal of Experimental & Clinical Cancer Research;2024-08-16

3. AN IN SILICO AND IN VITRO EVALUATION OF CYTOTOXICITY, APOPTOTIC ACTIVITY AND GENE EXPRESSION MODULATION OF SARSASAPOGENIN IN HUMAN COLORECTAL CANCER CELL LINE HT-29;International Journal of Applied Pharmaceutics;2024-07-07

4. Receptor-Targeted Nanomedicine for Cancer Therapy;Receptors;2024-07-03

5. Advancements in combining targeted therapy and immunotherapy for colorectal cancer;Trends in Cancer;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3